Profiel
Steen Kroyer is currently the Chairman at Maab International and Kroyer Consulting Ltd.
He was previously the Chief Executive Officer at Bionor Pharma ASA in 2013 and the Chief Executive Officer at Astrazeneca China Ltd.
He also served as a Director at Quiapeg Pharmaceuticals Holding AB from 2018 to 2022.
Actieve functies van Steen Kroyer
| Bedrijven | Functie | Begin |
|---|---|---|
| Maab International | Voorzitter | 01-07-2014 |
| Kroyer Consulting Ltd. | Voorzitter | 01-03-2014 |
Eerdere bekende functies van Steen Kroyer
| Bedrijven | Functie | Einde |
|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Voorzitter | 09-06-2022 |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | President | - |
| Astrazeneca China Ltd. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
| Astrazeneca China Ltd. | |
| Maab International | |
| Kroyer Consulting Ltd. |
